Back to Search
CAROL LINDSLEY, MD
MD
Pediatrics Physician
NPI: 1457461329Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
04-15746(KS)
Research & Publications (20)
Overview and report on international registry of sarcoid arthritis in childhood.
PMID 11123081·Curr Rheumatol Rep·2000
4-observational
Recent progress in the discovery and development of negative allosteric modulators of mGluR5.
PMID 19562641·Curr Opin Drug Discov Devel·2009
6-review
A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.
PMID 19407080·Mol Pharmacol·2009
7-preclinical
Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs).
PMID 19469556·J Med Chem·2009
7-preclinical
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin.
PMID 19443215·Bioorg Med Chem Lett·2009
7-preclinical
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity.
PMID 19268584·Bioorg Med Chem Lett·2009
8-other
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
PMID 19438238·J Med Chem·2009
7-preclinical
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
PMID 19435893·Cancer Res·2009
8-other
Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype.
PMID 19443219·Bioorg Med Chem Lett·2009
8-other
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.
PMID 19299128·Bioorg Med Chem Lett·2009
4-observational
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning.
PMID 19295507·Neuropsychopharmacology·2009
7-preclinical
Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2.
PMID 19279215·Proc Natl Acad Sci U S A·2009
8-other
Molecule of the month. FDA approves new treatment for fibromyalgia.
PMID 19241619·Curr Top Med Chem·2009
8-other
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.
PMID 19201489·Trends Pharmacol Sci·2009
6-review
Synthesis, SAR and unanticipated pharmacological profiles of analogues of the mGluR5 ago-potentiator ADX-47273.
PMID 19197923·ChemMedChem·2009
8-other
Discovery of GlyT1 inhibitors with improved pharmacokinetic properties.
PMID 19181525·Bioorg Med Chem Lett·2009
4-observational
Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4).
PMID 19640716·Bioorg Med Chem Lett·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3901 RAINBOW BLVD, 2026 MILLER MAIL STOP 4004
KANSAS CITY, KS 66160 - Phone
- (913) 588-6301
Quick Facts
- NPI
- 1457461329
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile